• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream

    4/16/25 7:00:00 AM ET
    $ASBP
    $BENF
    $BNZI
    $CIA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Finance: Consumer Services
    Finance
    Get the next $ASBP alert in real time by email

    MIAMI, April 16, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 80th Emerging Growth Conference on April 16 & 17, 2025.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    For updates, follow us on Twitter

    Day 1 - Today

    April 16, 2025

    9:00

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:20

    Introduction

    9:25 – 9:35

    Empire Energy (ASX: EEG)

    Keynote speaker: Alex Underwood, CEO & Managing Director

    9:40 – 10:10

    PSQ Holdings, Inc. (NYSE:PSQH)

    Keynote speaker: Michael Seifert, Founder, President / CEO

    10:50 – 11:20

    Ur-Energy (NYSE:URG) (TSX:URE)

    Keynote speaker: John W. Cash, CEO

    11:25 – 11:55

    Interstellar Communication Holdings

    Keynote speakers: Seda Hewitt, Space Ambassador of icMercury, Harri Laitinen, Lifeguard of icMercury, and Lijie Zhu, Captain of icMercury

    12:00 – 12:30

    U.S. Energy Corporation (NASDAQ:USEG)

    Keynote speaker: Ryan Smith, President, CEO & Director

    12:35 – 1:05

    Odyssey Marine Exploration, Inc. (NASDAQ:OMEX)

    Keynote speaker: Mark D. Gordon, Chairman & CEO

    1:10 – 1:40

    Nova Minerals Limited (NASDAQ:NVA) (ASX: NVA)

    Keynote speaker: Christopher Gerteisen – CEO & Executive Director

    1:45 – 2:15

    C3 Metals Inc. (TSXV:CCCM) (OTCQB:CUAUF)

    Keynote speaker: Daniel A. Symons, President, CEO & Director

    2:20 – 2:50

    Ucore Rare Metals, Inc. (OTCQX:UURAF) (TSXV:UCU)

    Keynote speaker: Pat Ryan, CEO

    2:55 – 3:05

    Eloro Resources, Ltd. (OTCQX:ELRRF) (TSX:ELO)

    Keynote speaker: Chris Holden – VP Corporate Development

    3:10 – 3:20

    Opawica Explorations Inc. (OTCQB:OPWEF) (TSXV:OPW)

    Keynote speaker: Blake Morgan, President / CEO

    3:25 – 3:35

    HydroGraph Clean Power Inc. (OTCQB:HGRAF) (CSE:HG)

    Keynote speaker: Kjirstin Breure, President and CEO

    3:40 – 3:50

    GeoVax Labs, Inc. (NASDAQ:GOVX)

    Keynote speaker: David Dodd, Chairman, President / CEO

    _______________________________________________________________

    Day 2 - Tomorrow

    April 17, 2025

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    SBC Medical Group Holdings, Inc. (NASDAQ:SBC) 

    Keynote speaker: Yuya Yoshida, Executive Vice President & CFO

    10:50 – 11:20

    Evofem Biosciences, Inc. (OTCQB:EVFM)

    Keynote speaker: Amy Raskopf, Chief Business Development Officer

    11:25 – 11:55

    Bioxytran, Inc. (OTCQB:BIXT) 

    Keynote speakers: Dr. David Platt, CEO & Mike Sheikh, Executive Vice President Business Development

    12:00 – 12:30

    Clene Inc., (NASDAQ:CLNN)

    Keynote speaker: Rob Etherington, President / CEO

    12:35 – 1:05

    Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP)

    Keynote speaker: Kraig Higginson – CEO

    1:10 – 1:40

    Regen BioPharma Inc. (OTC:RGBP)

    Keynote speakers: David Koos, President / CEO, & Harry M. Lander, Ph.D. Senior Scientific Consultant

    1:45 – 2:15

    Banzai International, Inc. (NASDAQ:BNZI)

    Keynote speaker: Joseph Davy, Co-Founder, Chairman & CEO

    2:55 – 3:05

    Citizens, Inc. (NYSE:CIA)

    Keynote speakers: Jon Stenberg, President / CEO, and Jeff Conklin, CFO

    3:10 – 3:20

    Sono Group N.V. (OTCQB:SEVCF)

    Keynote speaker: George O'Leary, Managing Director, CEO and CFO

    Postponed

    22nd Century Group, Inc. (NASDAQ:XXII)

    Keynote speaker: Lawrence D. Firestone, Chairman & CEO

    3:40 – 3:50

    Alt Equity

    Keynote speaker: Daniel Wait, President / Founder

    3:55 – 4:05

    Cyios Corp. (OTC:CYIO)

    Keynote speaker: John O'Shea, Chairman

    4:10 – 4:20

    Beneficient (NASDAQ:BENF)

    Keynote speaker: Brad K. Heppner, CEO

    Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: [email protected]



    Primary Logo

    Get the next $ASBP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASBP
    $BENF
    $BNZI
    $CIA

    CompanyDatePrice TargetRatingAnalyst
    Ur Energy Inc
    $URG
    4/3/2026Buy
    Canaccord Genuity
    Ur Energy Inc
    $URG
    4/2/2026Buy
    Canaccord Genuity
    SBC Medical Group Holdings Incorporated
    $SBC
    3/6/2026$8.00Buy
    BTIG Research
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    Ur Energy Inc
    $URG
    10/27/2025$2.15Outperform
    Northland Capital
    Ur Energy Inc
    $URG
    7/25/2025$3.00Buy
    Maxim Group
    Ur Energy Inc
    $URG
    7/23/2025$2.00Buy
    B. Riley Securities
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$18.00 → $14.00Buy
    D. Boral Capital
    More analyst ratings

    $ASBP
    $BENF
    $BNZI
    $CIA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Davy Joseph P.

    4 - Banzai International, Inc. (0001826011) (Issuer)

    4/9/26 8:00:03 PM ET
    $BNZI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Ugwumba Chidozie

    4 - Clene Inc. (0001822791) (Issuer)

    4/6/26 5:32:25 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Stenberg Jon

    4 - CITIZENS, INC. (0000024090) (Issuer)

    4/2/26 4:17:16 PM ET
    $CIA
    Life Insurance
    Finance

    $ASBP
    $BENF
    $BNZI
    $CIA
    SEC Filings

    View All

    SEC Form 424B3 filed by Beneficient

    424B3 - Beneficient (0001775734) (Filer)

    4/10/26 7:47:58 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    SEC Form DEFA14A filed by Beneficient

    DEFA14A - Beneficient (0001775734) (Filer)

    4/10/26 7:44:32 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    Beneficient filed SEC Form 8-K: Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Beneficient (0001775734) (Filer)

    4/10/26 7:40:52 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    $ASBP
    $BENF
    $BNZI
    $CIA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Ur-Energy

    Canaccord Genuity initiated coverage of Ur-Energy with a rating of Buy

    4/3/26 10:44:59 AM ET
    $URG
    Precious Metals
    Basic Materials

    Canaccord Genuity initiated coverage on Ur-Energy

    Canaccord Genuity initiated coverage of Ur-Energy with a rating of Buy

    4/2/26 8:22:26 AM ET
    $URG
    Precious Metals
    Basic Materials

    BTIG Research initiated coverage on SBC Medical Group with a new price target

    BTIG Research initiated coverage of SBC Medical Group with a rating of Buy and set a new price target of $8.00

    3/6/26 8:35:41 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $ASBP
    $BENF
    $BNZI
    $CIA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Matlin David J bought $216,664 worth of shares (33,333 units at $6.50), increasing direct ownership by 7% to 477,824 units (SEC Form 4)

    4 - Clene Inc. (0001822791) (Issuer)

    1/13/26 2:48:54 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Seifert Michael Stephen bought $10,000 worth of shares (7,143 units at $1.40), increasing direct ownership by 6% to 133,955 units (SEC Form 4)

    4 - PSQ Holdings, Inc. (0001847064) (Issuer)

    12/1/25 7:10:54 PM ET
    $PSQH
    Advertising
    Consumer Discretionary

    VICE PRESIDENT FINANCE Walle Jade bought $182,880 worth of shares (144,000 units at $1.27) (SEC Form 4)

    4 - UR-ENERGY INC (0001375205) (Issuer)

    11/21/25 5:06:49 PM ET
    $URG
    Precious Metals
    Basic Materials

    $ASBP
    $BENF
    $BNZI
    $CIA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $ASBP
    $BENF
    $BNZI
    $CIA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    Beneficient Closes $8.75 Million GP Primary Capital Transaction

    DALLAS, April 10, 2026 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced it has closed on the financing of an $8.75 million primary capital commitment in Quartus AI Fund LP ("Fund"), a fund managed by Quartus Capital Partners LLC ("Quartus"), a New York based investment firm investing in growth stage AI and technology ventures. Quartus is led by AI pioneers, technologists, and seasoned operators (the "Transaction"). The Transaction continues the Company's efforts to deliver primary capital

    4/10/26 7:30:00 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    American Ocean Minerals Corporation to Merge with Odyssey Marine Exploration, Inc., Creating a $1B U.S.-Controlled Deep-Sea Critical Minerals Platform

    Creates one of the largest U.S.-controlled critical minerals and rare earths platforms focused on deep-sea exploration, harvesting and processing of polymetallic nodules Led by Chairman Tom Albanese, former Rio Tinto CEO, and CEO Mark Justh, a 30-year financial services veteran; and supported by founding investor and special advisor Mike Rowe, the founder and CEO of the mikeroweWORKS foundation, nationally recognized media figure and advocate for reindustrialization and skilled trades development Diversified portfolio spanning U.S.-licensed international waters and allied sovereign waters, including two out of three exclusive licensed exploration areas in the critical mineral-rich Co

    4/8/26 7:30:00 AM ET
    $OMEX
    Marine Transportation
    Consumer Discretionary

    PSQ Holdings Announces Finance Leadership Transition

    James Rinn to step down as CFO, effective April 30, 2026, and will remain a member of the Board of Directors Michael Pena named Chief Financial Officer & Treasurer, effective May 1, 2026 Krista Wenzel named Chief Accounting Officer, effective May 1, 2026 PSQ Holdings, Inc. (NYSE:PSQH) (the "Company"), announced today that James Rinn, Chief Financial Officer (CFO), has resigned from his role, effective April 30, 2026, to pursue another opportunity. Mr. Rinn will remain a Class III Director after stepping down as CFO. Following Mr. Rinn's departure, effective May 1, 2026, Michael Pena, current Senior Vice President of Finance for the Company, has been named Chief Financial Officer a

    4/7/26 4:15:00 PM ET
    $PSQH
    Advertising
    Consumer Discretionary

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $ASBP
    $BENF
    $BNZI
    $CIA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by PSQ Holdings Inc.

    SC 13G - PSQ Holdings, Inc. (0001847064) (Subject)

    12/12/24 11:50:43 AM ET
    $PSQH
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    11/14/24 5:56:57 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $ASBP
    $BENF
    $BNZI
    $CIA
    Financials

    Live finance-specific insights

    View All

    American Ocean Minerals Corporation to Merge with Odyssey Marine Exploration, Inc., Creating a $1B U.S.-Controlled Deep-Sea Critical Minerals Platform

    Creates one of the largest U.S.-controlled critical minerals and rare earths platforms focused on deep-sea exploration, harvesting and processing of polymetallic nodules Led by Chairman Tom Albanese, former Rio Tinto CEO, and CEO Mark Justh, a 30-year financial services veteran; and supported by founding investor and special advisor Mike Rowe, the founder and CEO of the mikeroweWORKS foundation, nationally recognized media figure and advocate for reindustrialization and skilled trades development Diversified portfolio spanning U.S.-licensed international waters and allied sovereign waters, including two out of three exclusive licensed exploration areas in the critical mineral-rich Co

    4/8/26 7:30:00 AM ET
    $OMEX
    Marine Transportation
    Consumer Discretionary

    Banzai Reports Fourth Quarter and Full Year 2025 Financial Results

    Full Year 2025 Revenue of $12.2 Million, up 169% from 2024  Revenue of $2.8 Million for Q4 2025, up 116% from Q4 2024 Gross Profit of $2.3 Million for Q4 2025, a 148% increase from Q4 2024; Gross Margin Expanded to 81.9% in Q4 2025, a 1,061 BPS Increase Reaches Deal to Acquire Assets of ConnectAndSell, a Profitable Company, More Than Doubling Annual Revenue and Expanding AI Platform Capabilities Management to Host Fourth Quarter and Full Year 2025 Results Conference Call Today, Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time SEATTLE, March 31, 2026 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ:BNZI) ("Banzai" or the "Company"), a leading AI-powered sales & marketing techno

    3/31/26 4:10:00 PM ET
    $BNZI
    Computer Software: Prepackaged Software
    Technology

    SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results

    Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year

    3/27/26 6:40:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $ASBP
    $BENF
    $BNZI
    $CIA
    Leadership Updates

    Live Leadership Updates

    View All

    PSQ Holdings Announces Finance Leadership Transition

    James Rinn to step down as CFO, effective April 30, 2026, and will remain a member of the Board of Directors Michael Pena named Chief Financial Officer & Treasurer, effective May 1, 2026 Krista Wenzel named Chief Accounting Officer, effective May 1, 2026 PSQ Holdings, Inc. (NYSE:PSQH) (the "Company"), announced today that James Rinn, Chief Financial Officer (CFO), has resigned from his role, effective April 30, 2026, to pursue another opportunity. Mr. Rinn will remain a Class III Director after stepping down as CFO. Following Mr. Rinn's departure, effective May 1, 2026, Michael Pena, current Senior Vice President of Finance for the Company, has been named Chief Financial Officer a

    4/7/26 4:15:00 PM ET
    $PSQH
    Advertising
    Consumer Discretionary

    Beneficient Appoints Mack H. Hicks to Board of Directors

    DALLAS, March 12, 2026 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced the appointment of Mack H. Hicks as a member of the Company's Board of Directors (the "Board"). Mr. Hicks currently serves as Chief Executive Officer of Hicks Holdings LLC, the Dallas-based family office with operating private equity and real estate investment businesses founded by his late father and private equity pioneer, Thomas O. Hicks, who served as Chairman of the Board of Beneficient until his passing in December of 2025. Mr. Hicks also

    3/12/26 7:30:00 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    SBC Medical Appoints Sheng-FU Hsiao as CTO Leveraging Medical Big Data from 283 Global Locations and 6.63 Million Annual Patient Visits to Build a Scalable, AI-Driven Medical Management Infrastructure

    SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced the appointment of Sheng-FU Hsiao as Chief Technology Officer (CTO), effective March 1, 2026. This appointment aligns with the Company's 2026 management strategy, "Sophistication of Management Structure through AI and DX," and strengthens its leadership team to accelerate technological transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302064873/en/SBC Medical Appoints Sheng-FU Hsiao as CTO Leveraging

    3/2/26 7:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care